PDS Biotechnology Corporation
PDSB
$1.26
$0.021.61%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 2.83M | 3.37M | 4.16M | 3.39M | 2.94M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 7.36M | 10.18M | 8.68M | 10.10M | 10.41M |
| Operating Income | -7.36M | -10.18M | -8.68M | -10.10M | -10.41M |
| Income Before Tax | -7.95M | -10.73M | -9.20M | -10.60M | -10.90M |
| Income Tax Expenses | 0.00 | -- | -869.20K | -- | 0.00 |
| Earnings from Continuing Operations | -7.95M | -10.73M | -8.33M | -10.60M | -10.90M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -7.95M | -10.73M | -8.33M | -10.60M | -10.90M |
| EBIT | -7.36M | -10.18M | -8.68M | -10.10M | -10.41M |
| EBITDA | -7.35M | -10.16M | -8.67M | -10.08M | -10.39M |
| EPS Basic | -0.21 | -0.29 | -0.23 | -0.30 | -0.34 |
| Normalized Basic EPS | -0.13 | -0.18 | -0.16 | -0.19 | -0.22 |
| EPS Diluted | -0.21 | -0.29 | -0.23 | -0.30 | -0.34 |
| Normalized Diluted EPS | -0.13 | -0.18 | -0.16 | -0.19 | -0.22 |
| Average Basic Shares Outstanding | 37.49M | 36.81M | 36.69M | 34.82M | 31.66M |
| Average Diluted Shares Outstanding | 37.49M | 36.81M | 36.69M | 34.82M | 31.66M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |